Sugammadex use in liver transplantation: a case series and literature review

  • Leyla Iyilikci Dept of Anesthesiology and Reanimation, Faculty of Medicine, Dokuz Eylül University, Izmir, (Turkey)
  • Sule Ozbilgin Dept of Anesthesiology and Reanimation, Faculty of Medicine, Dokuz Eylül University, Izmir, (Turkey)
  • Mert Akan Dept of Anesthesiology and Reanimation, Faculty of Medicine, Dokuz Eylül University, Izmir, (Turkey
  • Sevda Ozkardesler Dept of Anesthesiology and Reanimation, Faculty of Medicine, Dokuz Eylül University, Izmir, (Turkey)
  • Leyla Seden Duru Dept of Anesthesiology and Reanimation, Hospital of Izmir University, Izmir, (Turkey)
Keywords: Liver transplantation, Sugammadex, Neuromuscular blockade, Endotracheal extubation, Rocuronium, Neuromuscular Nondepolarizing Agents

Abstract

Postoperative residual neuromuscular blockade is associated with significant morbidity in liver transplantation.
We report postoperative outcomes of sugammadex in a case series of 6 adult patients underwent
liver transplantation at our institution in 2013. Sugammadex administration did not lead to any differences
in the patients’ heart rates, mean arterial pressures and electrocardiograms. In this case series, we
observed that administration of rocuronium and sugammadex was effective and safe in liver transplant
recipients. Postoperative residual neuromuscular blockade reversal with sugammadex may reduce the
risk of pulmonary complications in liver transplant recipients.

Published
01-27-2019
How to Cite
Iyilikci, L., Ozbilgin, S., Akan, M., Ozkardesler, S., & Seden Duru, L. (2019). Sugammadex use in liver transplantation: a case series and literature review. Anaesthesia, Pain & Intensive Care, 376-379. Retrieved from https://apicareonline.com/index.php/APIC/article/view/346
Issue
Vol.19 No.3(2015): July-September
Section
Case Reports